Tag Archives: Viral Genetics

Viral Genetics Spins Out CU Technology into New Subsidiary

Viral Genetics announce the formation of a wholly-owned subsidiary MetaCytoLytics, Inc, which will focus on the development of “metabolic disruption technology.” The technology, to which Viral Genetics has the option to negotiate exclusive rights, was developed by Dr. Karen Newell, a professor at the University of Colorado at Colorado Springs. Metabolic disruption technology, [...]

Discoverer of HIV, Dr. Luc Montagnior, Joins Viral Genetics

Yesterday it was announced that Dr. Luc Montagnior, who co-discovered HIV in 1983, will join the scientific advisory team of California-based Viral Genetics. Viral Genetic’s drug VGV-1 has demonstrated significant results in reducing the viral load of AIDS patients in several international studies. VGV-1 is notable as an immune-based therapy, meaning that instead of directly [...]